SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Plotkin David

(Last) (First) (Middle)
C/O BRIGHTCOVE INC.
290 CONGRESS STREET

(Street)
BOSTON MA 02210

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/24/2017
3. Issuer Name and Ticker or Trading Symbol
BRIGHTCOVE INC [ BCOV ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel, SVP
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 17,790 D
Common Stock 3,750(1) D
Common Stock 7,500(2) D
Common Stock 2,250(3) D
Common Stock 5,333(4) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (5) 05/14/2020 Common Stock 2,692 9.308 D
Stock Option (right to buy) (6) 05/14/2020 Common Stock 192 9.308 D
Stock Option (right to buy) (7) 03/08/2021 Common Stock 518 8.19 D
Stock Option (right to buy) (8) 02/17/2022 Common Stock 3,846 11 D
Stock Option (right to buy) (9) 05/08/2022 Common Stock 2,000 16.88 D
Stock Option (right to buy) (10) 07/30/2023 Common Stock 8,000 10.61 D
Stock Option (right to buy) (11) 07/29/2024 Common Stock 5,000 5.97 D
Stock Option (right to buy) (12) 08/04/2025 Common Stock 15,000 5.53 D
Stock Option (right to buy) (13) 09/30/2025 Common Stock 10,000 4.92 D
Stock Option (right to buy) (14) 12/30/2025 Common Stock 9,000 6.35 D
Stock Option (right to buy) (15) 12/23/2026 Common Stock 10,667 8 D
Explanation of Responses:
1. Represents the unvested portion of a restricted stock unit award under the Brightcove Inc. 2012 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Brightcove Inc. common stock. The restricted stock units vest in four equal annual installments beginning on August 4, 2016.
2. Represents the unvested portion of a restricted stock unit award under the Brightcove Inc. 2012 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Brightcove Inc. common stock. The restricted stock units vest in four equal annual installments beginning on September 10, 2016.
3. Represents the unvested portion of a restricted stock unit award under the Brightcove Inc. 2012 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Brightcove Inc. common stock. The restricted stock units vest in four equal annual installments beginning on December 10, 2016.
4. Represents the unvested portion of a restricted stock unit award under the Brightcove Inc. 2012 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Brightcove Inc. common stock. The restricted stock units vest in four equal annual installments beginning on December 10, 2017.
5. This stock option was granted on May 14, 2010 and is fully vested.
6. This stock option was granted on May 14, 2010 and is fully vested.
7. This stock option was granted on March 8, 2011 and is fully vested.
8. This stock option was granted on February 17, 2012 and is fully vested.
9. This stock option was granted on May 8, 2012 and is fully vested.
10. This stock option was granted on July 30, 2013 and vests in four equal annual installments beginning on July 30, 2014.
11. This stock option was granted on July 29, 2014 and vests in four equal annual installments beginning on July 29, 2015.
12. This stock option was granted on August 4, 2015 and vests in four equal annual installments beginning on August 4, 2016.
13. This stock option was granted on September 30, 2015 and vests in four equal annual installments beginning on September 10, 2016.
14. This stock option was granted on December 30, 2015 and vests in four equal annual installments beginning on December 10, 2016.
15. This stock option was granted on December 23, 2016 and vests in four equal annual installments beginning on December 10, 2017.
Remarks:
Exhibit 24.1: Power of Attorney
/s/ David Plotkin 08/02/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                                                                    Exhibit 24.1

                           LIMITED POWER OF ATTORNEY

The undersigned hereby constitutes and appoints Christopher Keenan, with full
power of substitution, the undersigned's true and lawful attorney-in-fact to:

    (1)   Complete and execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer, director and/or ten percent (10%)
shareholder of Brightcove Inc., a Delaware corporation (the "Company") any and
all instruments, certificates and documents required to be executed on behalf of
the undersigned as an individual or on behalf of the undersigned's company or
partnership, as the case may be, pursuant to Section 13 and Section 16 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") or the rules
and regulations thereunder;

    (2)   Do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
instruments, certificates or documents required to be filed pursuant to Sections
13 and 16 of the Exchange Act or the rules or regulations thereunder and timely
file such forms with the United States Securities and Exchange Commission and
any stock exchange or similar authority; and

    (3)   Take any other action of any type whatsoever in
 connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by any such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.

    The undersigned hereby grants to each such attorney-in-fact, acting singly,
full power and authority to do and perform any and every act which is necessary,
proper or desirable to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that any such attorney-in-fact, or any such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted.

    The undersigned acknowledges that each of the foregoing attorneys-in-fact,
in serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 13 or Section 16 of the Exchange Act or the rules or regulations
thereunder.  The undersigned hereby agrees to indemnify each attorney-in-fact
and the Company from and against any demand, damage, loss, cost or expense
arising from any false or misleading information provided by the undersigned to
such attorney-in fact.

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file any instruments, certificates and
documents pursuant to Section 13 and 16 of the Exchange Act or the rules or
regulations thereunder with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of August 2, 2017

                            /s/ David Plotkin
                            -----------------
                            David Plotkin